2.4 Alpha and Beta Thalassemias

Alpha and Beta Thalassemias

Thalassemias represent a diverse group of hereditary microcytic, hemolytic anemias caused by quantitative defects in globin chain synthesis. Unlike qualitative hemoglobinopathies (such as Hb S or Hb C), where structurally abnormal globin chains are synthesized at normal rates, thalassemias feature structurally normal globin chains produced at significantly reduced rates or completely absent.

---

Pathophysiologic Principle: Unpaired Globin Chain Precipitation

The fundamental pathology common to all thalassemias is globin chain synthesis imbalance. When synthesis of one globin chain is diminished, the unaffected partner globin chains accumulate in excessive, unmatched quantities:

                     ┌─────────────────────────────────────────┐
                     │     Diminished Synthesis of One Chain   │
                     │       (Alpha or Beta Globin Gene)       │
                     └────────────────────┬────────────────────┘
                                          │
                                          ▼
                     ┌─────────────────────────────────────────┐
                     │  Accumulation of Excess Unpaired Chains │
                     └────────────────────┬────────────────────┘
                                          │
         ┌────────────────────────────────┴────────────────────────────────┐
         ▼                                                                 ▼
[In Beta Thalassemia: Free Alpha Monomers]             [In Alpha Thalassemia: Free Beta / Gamma Tetramers]
 • Highly insoluble, precipitate in erythroblasts       • Form soluble tetramers (Hb H = β₄, Hb Barts = γ₄)
 • Severe mechanical membrane damage                    • Precipitate in mature erythrocytes as cells age
 • Apoptosis in marrow (Ineffective Erythropoiesis)     • Chronic extravascular hemolysis & splenomegaly

1. Ineffective Erythropoiesis: In $\beta$-thalassemia, free $\alpha$-globin chains cannot form stable tetramers. Free $\alpha$-monomers precipitate inside developing bone marrow normoblasts, forming toxic inclusions that oxidize membrane lipids and proteins, triggering widespread apoptosis of erythroblasts before they can exit the marrow.
2. Extravascular Hemolysis: Erythrocytes that survive marrow maturation contain rigid inclusions. As they transit the splenic cords of Billroth, splenic macrophages recognize membrane damage and ingest the abnormal cells, causing chronic extravascular hemolysis.
3. Marrow Expansion & Skeletal Deformities: Severe anemia triggers massive compensatory secretion of erythropoietin, driving intense erythroid marrow expansion (up to 20–30 times normal). This causes bone cortex thinning, pathologic fractures, maxillary hyperplasia, frontal bossing, and classic "hair-on-end" (crew-cut) radiographic appearances on skull X-rays.

---

Alpha Thalassemias

Alpha thalassemia is governed by four functional $\alpha$-globin gene alleles (two identical tandem genes, $\alpha_2$ and $\alpha_1$, on each chromosome 16: designated $\alpha\alpha/\alpha\alpha$). Unlike $\beta$-thalassemia, which is predominantly caused by point mutations, $\alpha$-thalassemia is caused in >90% of cases by large gene deletions mediated by non-homologous crossing over during meiosis.

Chromosome 16 Configuration:   [ α2 │ α1 ] / [ α2 │ α1 ]  (Normal: 4 functional genes)

1 Deletion  (-α/αα) : Silent Carrier ────────► Normal CBC / Borderline MCV
2 Deletions (-α/-α) : Alpha Thal Minor (Trans) ──► Microcytosis, High RBC, Normal Electrophoresis
            (--/αα) : Alpha Thal Minor (Cis)   ──► High Risk of Hydrops in Offspring
3 Deletions (--/-α) : Hemoglobin H Disease ───► β₄ Tetramers, Golf Ball Inclusions, Fast Band
4 Deletions (--/--) : Hb Barts Hydrops Fetalis ► γ₄ Tetramers, Lethal in Utero

The Four Alpha Thalassemia Syndromes

1. Silent Carrier (One Gene Deletion: $-\alpha/\alpha\alpha$):
   • Three functional $\alpha$-genes maintain near-normal globin output.
   • Asymptomatic with normal complete blood count indices or borderline-low MCV (78–82 fL).
   • Hemoglobin electrophoresis in adults is completely normal (at birth, cord blood contains trace Hb Barts 1–2%).
2. Alpha Thalassemia Trait / Minor (Two Gene Deletions):
   • Trans Deletion ($-\alpha/-\alpha$): One $\alpha$-gene deleted on each chromosome 16. Highly prevalent in African populations; carriers can never produce an offspring with zero $\alpha$-genes ($--/--$).
   • Cis Deletion ($--/\alpha\alpha$): Both $\alpha$-genes deleted on the same chromosome 16. Highly prevalent in Southeast Asian and Mediterranean populations. Couples who are both cis carriers have a 25% risk of having a fetus with fatal Hb Barts Hydrops Fetalis ($--/--$).
   • Clinical/Lab Findings: Mild microcytic hypochromic anemia (Hb 10–12 g/dL, MCV 65–75 fL) with a disproportionately elevated RBC count ($>5.0\text{ to }5.5\times 10^{12}\text{/L}$). Routine adult hemoglobin electrophoresis is completely normal (Hb A >95%, Hb $A_2$ 1.5–3.5%, Hb F <1%) because the remaining two genes produce balanced chains.
3. Hemoglobin H Disease (Three Gene Deletions: $--/-\alpha$):
   • Severe deficiency of $\alpha$-chain synthesis. Excess unmatched $\beta$-chains aggregate into soluble tetramers of four beta chains ($\beta_4$ tetramers = Hemoglobin H).
   • Clinical Findings: Chronic moderate-to-severe hemolytic anemia (Hb 7–10 g/dL), splenomegaly, jaundice, and microcytosis (MCV 55–65 fL).
   • Supravital Incubation: When whole blood is incubated with Brilliant Cresyl Blue (BCB) or New Methylene Blue, redox dye action induces oxidative precipitation of Hb H, producing multiple fine, greenish-blue, evenly dispersed granules throughout erythrocytes, resembling a "golf ball" or "pitted raspberry".
   • Electrophoresis: Fast-migrating anodal band at alkaline pH representing Hb H (5–30%).
4. Hemoglobin Barts Hydrops Fetalis (Four Gene Deletions: $--/--$):
   • Complete absence of $\alpha$-globin chain synthesis. In fetal life, excess unmatched $\gamma$-chains aggregate into tetramers of four gamma chains ($\gamma_4$ tetramers = Hemoglobin Barts).
   • Pathophysiology: Hb Barts has an extremely high oxygen affinity ($P_{50} \sim 12\text{ mmHg}$ compared to normal $\sim 27\text{ mmHg}$) and cannot release oxygen to fetal tissues. This causes catastrophic intrauterine tissue hypoxia, massive hepatosplenomegaly, severe generalized edema (anasarca/hydrops fetalis), high-output cardiac failure, and intrauterine demise or death within minutes of birth.
   • Electrophoresis: 80–90% Hb Barts, absence of Hb A, Hb $A_2$, and Hb F, with small amounts of embryonic Hemoglobin Portland ($\zeta_2\gamma_2$).

---

Beta Thalassemias

Beta thalassemia is governed by two $\beta$-globin gene alleles (one gene on each chromosome 11: designated $\beta/\beta$). In contrast to $\alpha$-thalassemia, $\beta$-thalassemia is caused in >95% of cases by point mutations affecting transcription promoters, RNA splicing junctions, or nonsense/frameshift mutations:

• $\beta^0$ Allele: Complete absence of $\beta$-globin chain production.
• $\beta^+$ Allele: Markedly reduced (10–50% of normal) $\beta$-globin chain production.

1. Beta Thalassemia Minor / Trait (Heterozygous: $\beta^+/\beta$ or $\beta^0/\beta$)

Beta Thalassemia Minor is a common, clinically mild microcytic state that must be accurately differentiated from Iron Deficiency Anemia:

• CBC Profile: Mild microcytic hypochromic anemia (Hb 10–13 g/dL), marked microcytosis (MCV 58–70 fL), and a strikingly elevated red blood cell count ($>5.0\text{ to }6.5\times 10^{12}\text{/L}$) with a normal RDW (11.5–14.5%).
• Mentzer Index: Diagnostic mathematical ratio: $\text{Mentzer Index} = \frac{\text{MCV (fL)}}{\text{RBC Count } (10^{12}/\text{L})}$
  • Mentzer Index < 13: Strongly indicates Thalassemia Trait (the marrow generates many small microcytes).
  • Mentzer Index > 13: Strongly indicates Iron Deficiency Anemia (iron deficiency restricts total cell production, lowering RBC count relative to MCV).
• Definitive Diagnostic Hallmark: Quantification by HPLC or microcolumn chromatography demonstrates an elevated Hemoglobin $A_2$ (3.5% to 7.0%) (normal is 1.5–3.5%) and slightly elevated Hemoglobin F (1.0% to 3.0%).

2. Beta Thalassemia Intermedia (Homozygous/Compound Heterozygous: $\beta^+/\beta^+$ or $\beta^0/\beta^+$)

• Clinically intermediate between trait and major; patients maintain baseline Hb levels between 7.0 and 10.0 g/dL.
• Exhibit moderate splenomegaly, bone changes, and iron overload (from hyperabsorption driven by suppressed hepcidin), but remain transfusion-independent under baseline conditions.

3. Beta Thalassemia Major (Cooley Anemia: Homozygous $\beta^0/\beta^0$ or Severe $\beta^+/\beta^+$)

• Clinical Onset: Becomes clinically apparent between 6 and 9 months of age, as physiological fetal $\gamma$-to-$\beta$ globin chain switching occurs and Hb F production declines.
• Pathophysiology: Severe absence of $\beta$-chains leaves massive excess of free $\alpha$-chains, causing catastrophic ineffective erythropoiesis, profound anemia (Hb 3–6 g/dL), severe hepatosplenomegaly, and endocrine failure.
• Lifelong Management: Requires lifelong regular erythrocyte transfusions (every 2–4 weeks) paired with iron chelation therapy (deferoxamine, deferasirox) to prevent fatal secondary hemochromatosis (cardiac failure, hepatic cirrhosis).
• Peripheral Smear Morphology: Severe anisopoikilocytosis, microcytic hypochromic "ghost-like" cells, abundant target cells (codocytes), teardrop cells (dacrocytes), marked basophilic stippling, and a dramatic shower of nucleated red blood cells (NRBCs: 20–100+ per 100 WBCs).
• Electrophoresis / HPLC: Hemoglobin F > 90%, variable Hb $A_2$, and completely absent Hb A (in $\beta^0/\beta^0$) or trace Hb A (in $\beta^+/\beta^+$).

---

Delta-Beta Thalassemia & Hereditary Persistence of Fetal Hemoglobin (HPFH)

• $\delta\beta$-Thalassemia: Deletion of both adjacent $\delta$ and $\beta$ genes on chromosome 11. Homozygotes produce 100% Hb F with mild microcytic hypochromic anemia; heterozygotes produce 5–20% Hb F with normal or decreased Hb $A_2$.
• Hereditary Persistence of Fetal Hemoglobin (HPFH): Genetic deletion or promoter point mutations that prevent the normal developmental silencing of $\gamma$-globin gene expression in adulthood. Homozygotes have 100% Hb F with completely normal red cell lifespan, normal indices, and no anemia because $\gamma$-chains fully compensate for $\beta$-chains.
• Intracellular Distribution of Hb F:
  • Pancellular (Homogeneous): Hb F is distributed uniformly across 100% of erythrocytes (classic for HPFH).
  • Heterocellular (Heterogeneous): Hb F is distributed unevenly among a subpopulation of red blood cells ("F-cells") (classic for $\delta\beta$-thalassemia, $\beta$-thalassemia, and Sickle Cell Anemia).

---

The Kleihauer-Betke Acid Elution Test

                         Kleihauer-Betke Acid Elution Principle

[Blood Smear Fixed in 80% Ethanol] ──► [Incubated in Citrate Buffer (pH 3.2 - 3.3)]
                                                         │
                     ┌───────────────────────────────────┴───────────────────────────────────┐
                     ▼                                                                       ▼
         [Adult Hemoglobin (Hb A)]                                               [Fetal Hemoglobin (Hb F)]
      • Acid-SOLUBLE                                                          • Acid-RESISTANT
      • Elutes completely from erythrocytes                                   • Remains precipitated inside cells
      • Appears as colorless 'Ghost Cells'                                    • Stains DEEP PINK with Eosin/Erythrosin

Principle and Methodology

The Kleihauer-Betke (KB) test is a quantitative acid elution slide assay used to differentiate and count fetal red blood cells in maternal circulation:

1. A peripheral blood smear is prepared, fixed in 80% ethanol, and immersed in an acid buffer (citric acid-phosphate, pH 3.2–3.3) at 37°C.
2. Adult hemoglobin (Hb A) is acid-soluble; it rapidly dissolves and elutes out of maternal erythrocytes into the buffer, leaving empty, colorless, translucent cell membranes ("ghost cells" or stroma).
3. Fetal hemoglobin (Hb F) is structurally resistant to acid elution; it remains precipitated inside fetal erythrocytes.
4. The smear is counterstained with erythrosin B or eosin. Under microscopic evaluation, fetal cells stain dark, bright pink/red, while maternal cells appear as pale, unstained ghost outlines.

Clinical Application: Fetomaternal Hemorrhage (FMH) & RhIG Dosing

The KB test quantifies the volume of fetomaternal hemorrhage (FMH) in Rh-negative mothers who give birth to Rh-positive infants, determining the required dose of Rh Immune Globulin (RhIG / RhoGAM):

$\text{Fetal Cells (\%)} = \frac{\text{Number of Pink Fetal Cells}}{\text{Total Cells Counted (2,000)}} \times 100$

$\text{Fetal Whole Blood (mL)} = \text{Fetal Cells (\%)} \times 50$

$\text{Vials of RhIG (300 }\mu\text{g)} = \frac{\text{Fetal Whole Blood (mL)}}{30} + 1\text{ (Safety Buffer)}$

• Rounding Rule: When calculating the number of vials, divide the fetal whole blood volume by 30. If the decimal is $\ge 0.5$, round up to the next whole number and add 1 vial. If the decimal is $< 0.5$, round down to the whole number and add 1 vial.

---

Comprehensive Thalassemia Syndromes Reference Matrix